Shanghai, China Shanghai Creation Investment appeared to be the VC, which was created in 2006. The leading representative office of defined VC is situated in the Shanghai. The venture was found in Asia in China.
The high activity for fund was in 2016. The fund is generally included in less than 2 deals every year. The real fund results show that this VC is 55 percentage points more often commits exit comparing to other companies. Comparing to the other companies, this Shanghai Creation Investment performs on 4 percentage points less the average number of lead investments. The common things for fund are deals in the range of 5 - 10 millions dollars.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Shanghai Creation Investment, startups are often financed by General Technology Venture Capital. The meaningful sponsors for the fund in investment in the same round are ZGC Group, Waarde Capital, Robert Bosch Venture Capital. In the next rounds fund is usually obtained by Avacare Health Group.
Among the most successful fund investment fields, there are Energy, Clinical Trials. For fund there is no match between the location of its establishment and the land of its numerous investments - Israel. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Biop-Medical, Cygnus Biosciences. The fund has exact preference in a number of founders of portfolio startups.
We also calculated 3 valuable employees in our database.
Related Funds
| Fund Name | Location |
| Akron Archangels | Akron, Ohio, United States |
| Amer International Group | China, Guangdong, Shenzhen |
| Blumenstein/Thorne Information Partners | Illinois, Lake Forest, United States |
| Darling Ventures | California, San Francisco, United States |
| Delaney Capital | United States, Washington, Yakima |
| Gramercy Ventures | California, San Francisco, United States |
| James Richardson & Sons | Canada, Manitoba, Winnipeg |
| Kuka Home | China, Hangzhou, Zhejiang |
| LANXESS | Cologne, Germany, Nordrhein-Westfalen |
| LifeForce Capital | California, San Francisco, United States |
| Marelli | Japan, Saitama, Saitama Prefecture |
| Mimecast | - |
| Next Level Ventures | Des Moines, Iowa, United States |
| Nextel Communications | Kansas, Overland Park, United States |
| Nippon Rent-A-Car | Japan, Miyakojima, Okinawa Prefecture |
| Rasmuson Foundation | Alaska, Anchorage, United States |
| Resonant Venture Partners | Ann Arbor, Michigan, United States |
| Woomi construction corporation | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Meio Medical | 14 Aug 2023 | Hangzhou, Zhejiang, China | |||
Shende Medical Equipment Technology | $15M | 14 Dec 2021 | Shanghai, Shanghai, China | ||
Simcere Pharma | $92M | 04 Jun 2021 | Xuanwu District, Jiangsu, China | ||
Cygnus Biosciences | $19M | 14 Nov 2017 | Changping District, Beijing, China | ||
Biop-Medical | $2M | 06 Apr 2016 | North District |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Meio Medical | 14 Aug 2023 | Hangzhou, Zhejiang, China | |||
Shende Medical Equipment Technology | $15M | 14 Dec 2021 | Shanghai, Shanghai, China | ||
Simcere Pharma | $92M | 04 Jun 2021 | Xuanwu District, Jiangsu, China | ||
Cygnus Biosciences | $19M | 14 Nov 2017 | Changping District, Beijing, China | ||
Biop-Medical | $2M | 06 Apr 2016 | North District |
